| 000 | 01453 a2200385 4500 | ||
|---|---|---|---|
| 005 | 20250515162333.0 | ||
| 264 | 0 | _c20090619 | |
| 008 | 200906s 0 0 eng d | ||
| 022 | _a0896-8608 | ||
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aWang, Angela Yee-Moon | |
| 245 | 0 | 0 |
_aVascular and other tissue calcification in peritoneal dialysis patients. _h[electronic resource] |
| 260 |
_bPeritoneal dialysis international : journal of the International Society for Peritoneal Dialysis _cFeb 2009 |
||
| 300 |
_aS9-S14 p. _bdigital |
||
| 500 | _aPublication Type: Journal Article; Review | ||
| 650 | 0 | 4 | _a1-Carboxyglutamic Acid |
| 650 | 0 | 4 |
_aBlood Proteins _xmetabolism |
| 650 | 0 | 4 |
_aBlood Vessels _xpathology |
| 650 | 0 | 4 |
_aC-Reactive Protein _xmetabolism |
| 650 | 0 | 4 |
_aCalcinosis _xblood |
| 650 | 0 | 4 |
_aCalcium-Binding Proteins _xblood |
| 650 | 0 | 4 |
_aExtracellular Matrix Proteins _xblood |
| 650 | 0 | 4 |
_aHeart Valve Diseases _xblood |
| 650 | 0 | 4 |
_aHeart Valves _xpathology |
| 650 | 0 | 4 | _aHumans |
| 650 | 0 | 4 |
_aKidney Failure, Chronic _xtherapy |
| 650 | 0 | 4 |
_aOsteoprotegerin _xblood |
| 650 | 0 | 4 |
_aPeritoneal Dialysis _xadverse effects |
| 650 | 0 | 4 | _aPrevalence |
| 650 | 0 | 4 | _aPrognosis |
| 650 | 0 | 4 |
_aVascular Diseases _xblood |
| 650 | 0 | 4 | _aalpha-2-HS-Glycoprotein |
| 650 | 0 | 4 | _aMatrix Gla Protein |
| 773 | 0 |
_tPeritoneal dialysis international : journal of the International Society for Peritoneal Dialysis _gvol. 29 Suppl 2 _gp. S9-S14 |
|
| 999 |
_c18710384 _d18710384 |
||